ERGOMED: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ERGOMED
Largest movements
- Receivables within one year -€7,709
down €7,709 (-22.5%), from €34,223 to €26,514
of which Trade receivables: -€7,566
- Stocks and contracts -€6,472
down €6,472 (-97.5%), from €6,639 to €167
- Profit (loss) carried forward +€19,561
up €19,561 (+38.6%), from -€50,703 to -€31,142
- Trade debts -€17,025
down €17,025 (-80.7%), from €21,085 to €4,061
- Short-term financial debts -€8,770
down €8,770 (-43.2%), from €20,323 to €11,553
- Tax, wage and social debts -€8,240
down €8,240 (-79.8%), from €10,330 to €2,090
of which Taxes: -€4,823
- Staff costs -€30,001
down €30,001 (-99.8%), from €30,071 to €69
- Gross operating margin -€25,349
down €25,349 (-49.3%), from €51,448 to €26,100
- Write-downs +€4,028
up €4,028 (+98.4%), from -€4,094 to -€66
- Financial charges -€1,792
down €1,792 (-38.1%), from €4,699 to €2,907
- Other operating charges -€1,484
down €1,484 (-76.9%), from €1,929 to €446
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Cash or the result is not a separate line in both sets of accounts; the cash flow cannot be derived from them.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €41,155 | €26,681 | -€14,474 | -35.2% |
| Current assets | 29/58 | €41,155 | €26,681 | -€14,474 | -35.2% |
| Stocks and contracts in progress | 3 | €6,639 | €167 | -€6,472 | -97.5% |
| Stocks | 30/36 | €6,639 | €167 | -€6,472 | -97.5% |
| Amounts receivable within one year | 40/41 | €34,223 | €26,514 | -€7,709 | -22.5% |
| Trade receivables | 40 | €34,080 | €26,514 | -€7,566 | -22.2% |
| Other amounts receivable | 41 | €142 | - | -€142 | |
| Deferred charges and accrued income | 490/1 | €293 | - | -€293 | |
| Total equity and liabilities | 10/49 | €41,155 | €26,681 | -€14,474 | -35.2% |
| Equity | 10/15 | -€33,843 | -€14,282 | +€19,561 | +57.8% |
| Contributions | 10/11 | €15,000 | €15,000 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€50,703 | -€31,142 | +€19,561 | +38.6% |
| Amounts payable | 17/49 | €74,997 | €40,963 | -€34,035 | -45.4% |
| Amounts payable within one year | 42/48 | €74,997 | €40,963 | -€34,035 | -45.4% |
| Financial debts | 43 | €20,323 | €11,553 | -€8,770 | -43.2% |
| Credit institutions | 430/8 | €20,323 | €11,553 | -€8,770 | -43.2% |
| Trade debts | 44 | €21,085 | €4,061 | -€17,025 | -80.7% |
| Suppliers | 440/4 | €21,085 | €4,061 | -€17,025 | -80.7% |
| Taxes, remuneration and social security | 45 | €10,330 | €2,090 | -€8,240 | -79.8% |
| Taxes | 450/3 | €6,759 | €1,936 | -€4,823 | -71.4% |
| Remuneration and social security | 454/9 | €3,571 | €154 | -€3,417 | -95.7% |
| Other amounts payable | 47/48 | €23,259 | €23,259 | = | 0.0% |
| Remuneration, social security and pensions | 62 | €30,071 | €69 | -€30,001 | -99.8% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | -€4,094 | -€66 | +€4,028 | +98.4% |
| Other operating charges | 640/8 | €1,929 | €446 | -€1,484 | -76.9% |
| Non-recurring operating charges | 66A | €13,915 | €3,103 | -€10,811 | -77.7% |
| Gross operating margin | 9900 | €51,448 | €26,100 | -€25,349 | -49.3% |
| Operating profit (loss) | 9901 | €9,628 | €22,547 | +€12,919 | +134.2% |
| Financial income | 75/76B | €258 | - | -€258 | |
| Recurring financial income | 75 | €258 | - | -€258 | |
| Financial charges | 65/66B | €4,699 | €2,907 | -€1,792 | -38.1% |
| Recurring financial charges | 65 | €4,699 | €2,907 | -€1,792 | -38.1% |
| Profit (loss) for the period before taxes | 9903 | €5,187 | €19,640 | +€14,453 | +278.6% |
| Income taxes | 67/77 | €304 | €79 | -€225 | -73.9% |
| Profit (loss) for the period | 9904 | €4,883 | €19,561 | +€14,678 | +300.6% |
| Profit (loss) for the period to be appropriated | 9905 | €4,883 | €19,561 | +€14,678 | +300.6% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.